Home » Laboratory Test May Predict Effectiveness of Erbitux for Cancer Patients
Laboratory Test May Predict Effectiveness of Erbitux for Cancer Patients
June 1, 2009
Precision Therapeutics, Inc. presented data demonstrating the use of ChemoFX, a chemosensitivity assay, to predict the effectiveness of cetuximab (ERBITUX) on the colorectal cancer cells of individual patients.
Triangle Business Journal
Triangle Business Journal
Upcoming Events
-
21Oct